Nemaura Medical Inc. (NMRD)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -7.28 Million USD | -11.31% |
| 2022 | -7.34 Million USD | -63.54% |
| 2021 | -4.48 Million USD | 4.97% |
| 2020 | -4.72 Million USD | -6.31% |
| 2019 | -4.44 Million USD | -136.38% |
| 2018 | -1.87 Million USD | -22.79% |
| 2017 | -1.53 Million USD | -0.56% |
| 2016 | -1.52 Million USD | -16.0% |
| 2015 | -1.31 Million USD | -125.81% |
| 2014 | -581.13 Thousand USD | 29.8% |
| 2013 | -827.84 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -1.96 Million USD | 41.42% |
| 2024 Q3 | -1.46 Million USD | 92.42% |
| 2024 Q2 | -1.91 Million USD | -11.8% |
| 2023 Q2 | -1.55 Million USD | 26.59% |
| 2023 FY | - USD | -11.31% |
| 2023 Q4 | -2.24 Million USD | -318.15% |
| 2023 Q3 | -537.41 Thousand USD | 65.34% |
| 2023 Q1 | -2.11 Million USD | 10.22% |
| 2022 Q4 | -2.35 Million USD | -35.64% |
| 2022 Q1 | -1.58 Million USD | -17.4% |
| 2022 Q2 | -1.66 Million USD | -5.35% |
| 2022 Q3 | -1.73 Million USD | -3.9% |
| 2022 FY | - USD | -63.54% |
| 2021 Q3 | -1.04 Million USD | 13.78% |
| 2021 FY | - USD | 4.97% |
| 2021 Q4 | -1.34 Million USD | -29.66% |
| 2021 Q1 | -890.86 Thousand USD | 33.5% |
| 2021 Q2 | -1.2 Million USD | -35.51% |
| 2020 Q2 | -1.09 Million USD | 11.61% |
| 2020 Q1 | -1.24 Million USD | 22.87% |
| 2020 FY | - USD | -6.31% |
| 2020 Q4 | -1.33 Million USD | -28.79% |
| 2020 Q3 | -1.04 Million USD | 5.42% |
| 2019 Q1 | -765.18 Thousand USD | -36.4% |
| 2019 FY | - USD | -136.38% |
| 2019 Q4 | -1.61 Million USD | -75.2% |
| 2019 Q3 | -920.65 Thousand USD | 19.56% |
| 2019 Q2 | -1.14 Million USD | -49.57% |
| 2018 Q4 | -560.98 Thousand USD | -19.63% |
| 2018 Q3 | -468.91 Thousand USD | -7.17% |
| 2018 Q2 | -437.55 Thousand USD | -6.14% |
| 2018 Q1 | -412.25 Thousand USD | -16.31% |
| 2018 FY | - USD | -22.79% |
| 2017 FY | - USD | -0.56% |
| 2017 Q4 | -354.43 Thousand USD | 4.41% |
| 2017 Q3 | -370.77 Thousand USD | -17.2% |
| 2017 Q2 | -316.36 Thousand USD | 35.34% |
| 2017 Q1 | -489.26 Thousand USD | -18.53% |
| 2016 Q1 | -398.74 Thousand USD | 25.32% |
| 2016 FY | - USD | -16.0% |
| 2016 Q4 | -412.76 Thousand USD | -26.93% |
| 2016 Q3 | -325.18 Thousand USD | 15.65% |
| 2016 Q2 | -385.53 Thousand USD | 3.31% |
| 2015 Q4 | -533.91 Thousand USD | -244.34% |
| 2015 FY | - USD | -125.81% |
| 2015 Q1 | -267.84 Thousand USD | -68.18% |
| 2015 Q2 | -355.46 Thousand USD | -32.71% |
| 2015 Q3 | -155.05 Thousand USD | 56.38% |
| 2014 Q1 | -61.05 Thousand USD | 70.5% |
| 2014 Q3 | -339.05 Thousand USD | -1457.87% |
| 2014 Q4 | -159.25 Thousand USD | 53.03% |
| 2014 FY | - USD | 29.8% |
| 2014 Q2 | -21.76 Thousand USD | 64.35% |
| 2013 Q4 | -206.96 Thousand USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 45.97% |
| Cerus Corporation | -26.53 Million USD | 72.539% |
| OrthoPediatrics Corp. | -8.38 Million USD | 13.053% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 30.563% |
| Talis Biomedical Corporation | -66.04 Million USD | 88.967% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 56.3% |
| Inogen, Inc. | -45.67 Million USD | 84.047% |
| Spectral AI, Inc. | -12.26 Million USD | 40.572% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 84.721% |
| CVRx, Inc. | -38.73 Million USD | 81.185% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -106.549% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 39.811% |
| Orthofix Medical Inc. | -86.98 Million USD | 91.623% |
| Venus Concept Inc. | -26.11 Million USD | 72.094% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 85.359% |
| Bioventus Inc. | -23.07 Million USD | 68.413% |
| BrainsWay Ltd. | -2.31 Million USD | -215.321% |
| Envoy Medical, Inc. | -18.23 Million USD | 60.045% |
| electroCore, Inc. | -17.76 Million USD | 58.969% |
| IceCure Medical Ltd | -15.25 Million USD | 52.225% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 85.353% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 56.768% |
| MaxCyte, Inc. | -44.12 Million USD | 83.487% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 38.014% |
| Nexalin Technology, Inc. | -5.69 Million USD | -28.022% |
| PAVmed Inc | -75.74 Million USD | 90.379% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 86.445% |
| RxSight, Inc. | -41.03 Million USD | 82.243% |
| Sight Sciences, Inc. | -49.41 Million USD | 85.253% |
| SI-BONE, Inc. | -34.44 Million USD | 78.845% |
| TELA Bio, Inc. | -40.63 Million USD | 82.066% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 87.5% |
| Treace Medical Concepts, Inc. | -39 Million USD | 81.319% |
| LivaNova PLC | 39.01 Million USD | 118.677% |
| 908 Devices Inc. | -34.02 Million USD | 78.583% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 93.411% |
| NeuroPace, Inc. | -22.83 Million USD | 68.087% |
| LENSAR, Inc. | -8.71 Million USD | 16.375% |
| Apyx Medical Corporation | -18.11 Million USD | 59.767% |
| Cutera, Inc. | -136.56 Million USD | 94.664% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -115.593% |
| BioSig Technologies, Inc. | -28.15 Million USD | 74.114% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 389.629% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 65.282% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 101.9% |
| Axonics, Inc. | 7.77 Million USD | 193.724% |
| Outset Medical, Inc. | -153.78 Million USD | 95.262% |
| IRIDEX Corporation | -7.44 Million USD | 2.161% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 92.571% |
| IRadimed Corporation | 20.8 Million USD | 135.033% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 9.612% |
| INVO Bioscience, Inc. | -6.88 Million USD | -5.916% |
| Telesis Bio, Inc. | -40.49 Million USD | 82.004% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 119.868% |
| Varex Imaging Corporation | 67.2 Million USD | 110.844% |
| Quipt Home Medical Corp. | 44.07 Million USD | 116.535% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 32.962% |
| Pulmonx Corporation | -55.09 Million USD | 86.773% |
| Dynatronics Corporation | -976 Thousand USD | -646.619% |
| Modular Medical, Inc. | -17.1 Million USD | 57.393% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 49.692% |
| Semler Scientific, Inc. | 23.58 Million USD | 130.892% |
| InMode Ltd. | 196.28 Million USD | 103.713% |
| Bruker Corporation | 599 Million USD | 101.217% |
| Cytosorbents Corporation | -28.81 Million USD | 74.707% |
| DexCom, Inc. | 916.7 Million USD | 100.795% |
| Align Technology, Inc. | 799.03 Million USD | 100.912% |
| Viveve Medical, Inc. | -20.61 Million USD | 64.655% |
| ZimVie Inc. | 91.07 Million USD | 108.001% |
| Movano Inc. | -29.12 Million USD | 74.98% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -65.314% |
| Nexalin Technology, Inc. | -5.69 Million USD | -28.022% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -106.549% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 96.256% |
| Profound Medical Corp. | -27.12 Million USD | 73.134% |
| Insulet Corporation | 323.6 Million USD | 102.252% |
| enVVeno Medical Corporation | -25.01 Million USD | 70.873% |
| Surmodics, Inc. | 1.18 Million USD | 713.389% |
| iCAD, Inc. | -6.56 Million USD | -10.999% |
| Nuwellis, Inc. | -16.35 Million USD | 55.447% |
| Biotricity, Inc. | -8.82 Million USD | 17.458% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 92.477% |
| Aethlon Medical, Inc. | -11.84 Million USD | 38.501% |
| InspireMD, Inc. | -20.91 Million USD | 65.152% |
| PAVmed Inc. | -75.74 Million USD | 90.379% |
| BIOLASE, Inc. | -15.13 Million USD | 51.866% |
| Beyond Air, Inc. | -59.03 Million USD | 87.656% |
| FONAR Corporation | 28.25 Million USD | 125.793% |
| AxoGen, Inc. | -13.32 Million USD | 45.325% |
| Vivani Medical, Inc. | -26.6 Million USD | 72.613% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 129.693% |
| Inari Medical, Inc. | 7.11 Million USD | 202.447% |
| UFP Technologies, Inc. | 72.74 Million USD | 110.018% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -115.225% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -18.373% |
| Tenon Medical, Inc. | -15.52 Million USD | 53.072% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 52.266% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 82.431% |
| AdaptHealth Corp. | -171.09 Million USD | 95.741% |
| Sintx Technologies, Inc. | -6.6 Million USD | -10.41% |
| NanoVibronix, Inc. | -3.43 Million USD | -112.141% |
| Quanterix Corporation | -38.08 Million USD | 80.868% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 32.962% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 24390.19% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 97.372% |
| TransMedics Group, Inc. | -7.6 Million USD | 4.156% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 66.519% |
| NeuroMetrix, Inc. | -7.09 Million USD | -2.695% |
| Hyperfine, Inc. | -47.06 Million USD | 84.516% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 87.502% |
| Biomerica, Inc. | -5.99 Million USD | -21.593% |
| Bone Biologics Corporation | 479.57 Thousand USD | 1619.492% |
| AVITA Medical, Inc. | -39.56 Million USD | 81.583% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 20.559% |
| Silk Road Medical, Inc | -45.08 Million USD | 83.835% |